I'd Take IBM's Problems

It's the same story from IBM (NYSE: IBM  ) , but it never really gets old.

In the face of a possible American recession, Big Blue delivered 28% earnings growth on 13% higher revenue, based on balanced performance across the globe in various product categories, with a healthy mix of supporting services. $26.8 billion in sales is nothing to sneeze at, nor is $1.98 of earnings per share for an earnings yield of 6.3% at the current run rate. Good luck finding a savings account with that kind of return on your invested capital.

Oracle (Nasdaq: ORCL  ) would be very satisfied with a 28% year-over-year earnings improvement, and Larry Ellison is probably gritting his teeth right now at his biggest rival's success. The same goes for German enterprise software competitor SAP AG (NYSE: SAP  ) or even domestic nemesis Microsoft (Nasdaq: MSFT  ) -- any of these guys would take IBM's numbers over their own at the moment.

And it looks like the success story will continue. "We entered the second quarter with a strong deal pipeline and this quarter, frankly, we were sold out," said CFO Mark Loughridge. Large contracts with pharma giant Pfizer (NYSE: PFE  ) and office equipment biggie Ricoh (OTC BB: RICOY) helped Big Blue saturate its order capacity, and the next quarter should be just as impressive as this one.

One of the biggest tech businesses in the world has completely filled its order book? Now that’s a nice problem to have. Keep looking for trouble, IBM.

Further Foolishness:

Pfizer is a Motley Fool Income Investor selection. Pfizer and Microsoft are Motley Fool Inside Value recommendations. Try any of our Foolish newsletters today, free for 30 days.

Fool contributor Anders Bylund holds no position in any of the companies discussed here. You can check out Anders' holdings if you like, and Foolish disclosure is always looking for the right kind of trouble.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 688255, ~/Articles/ArticleHandler.aspx, 10/25/2016 5:24:27 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/25/2016 4:01 PM
IBM $150.88 Up +0.31 +0.21%
IBM CAPS Rating: ****
MSFT $60.99 Down -0.01 -0.02%
Microsoft CAPS Rating: ****
ORCL $38.36 Up +0.09 +0.24%
Oracle CAPS Rating: ****
PFE $32.28 Up +0.15 +0.47%
Pfizer CAPS Rating: ****
SAP $88.31 Down -0.02 -0.02%
SAP AG (ADR) CAPS Rating: ****